Company Search:
Advanced Search
Sponsored Links
Mitsubishi Tanabe Pharma Corp Company Snapshot
Mitsubishi Tanabe Pharma Corp operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Mitsubishi Tanabe Pharma Corp with three other companies in this sector in Japan: Eisai Company Limited (2016 sales of 547.92 billion Japanese Yen [US$4.78 billion] of which 49% was Pharmaceutical Business -Japan), Taisho Pharmaceutical Holdings Co Ltd (290.14 billion Japanese Yen [US$2.53 billion] of which 62% was Self-medication), and Shionogi & Co Ltd (309.97 billion Japanese Yen [US$2.71 billion] of which 100% was Pharmaceuticals).

Sales Analysis. During the year ended March of 2016, sales at Mitsubishi Tanabe Pharma Corp were ¥431.70 billion (US$3.77 billion). This is an increase of 4.0% versus 2015, when the company's sales were ¥415.12 billion. The sales level in 2016 was fairly close to the level five years ago: in 2011, Mitsubishi Tanabe Pharma Corp had sales of ¥409.54 billion.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Mitsubishi Tanabe Pharma Corp
  Stock Performance Chart for Mitsubishi Tanabe Pharma Corp
  Stock Data: Recent Stock Performance:
  Current Price (1/13/2017): 2,277.00
(Figures in Japanese Yen)
1 Week -2.3%   13 Weeks 1.0%  
4 Weeks 4.4%   52 Weeks 15.5%  
Mitsubishi Tanabe Pharma Corp Key Data:
  Ticker: 4508 Country: Japan
  Exchanges: TYO OTH Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2016 Sales 431,701,000,000
(Year Ending Jan 2017).
Employees: 8,125
  Currency: Japanese Yen Market Cap: 1,277,371,249,407
  Fiscal Yr Ends: March Shares Outstanding: 560,988,691
  Share Type: Common Closely Held Shares: 331,275,616
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.